Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07069933
PHASE2

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

Sponsor: Mansoura University

View on ClinicalTrials.gov

Summary

A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of Itraconazole as an adjuvant therapy in treatment of patients with acute myeloid Leukemia.

Official title: "Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?"

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-07

Completion Date

2025-12

Last Updated

2025-07-17

Healthy Volunteers

Yes

Interventions

DRUG

Standard care +itraconazole 200mg

Is an antifungal used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals.

DRUG

Chemotherapy

Standard Care (in control arm)

Locations (1)

Clinical Oncology and Nuclear Medicine of Mansoura University Hospital, Mansoura,

Al Mansurah, Egypt